Pillstats
Rx only · Tablet, Extended Release · Oral

Darifenacin

Darifenacin Hydrobromide

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)136198
US makers4 labelers
Packages30
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.162$0.325$0.487$0.649Dec 2025Apr 2026Jul 2026
$0.486
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
4
Active US suppliers
73%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3156309451.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
815
Rx · 2026 Q1
32K
Units dispensed
-26%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown16SUPPLYING
Macleods Pharmaceuticals Limitedunknown6SUPPLYING
Torrent Pharmaceuticals Limitedunknown6SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): Darifenacin Extended-release Tablets 7.5 mg 30 Tablets Rx only Manufactured by: Torrent Pharmaceuticals LTD. Indrad-382…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC

  • Mar 15, 2021
    RECALLRecall (Class II): Darifenacin Extended-release Tablets 15 mg 30 Tablets Rx only, Manufactured by: Torrent Pharmaceuticals, LTD Indrad-38…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC